Characterizing Carbapenemase Gene Spread in Enterobacter cloacae: New Evidence from Guangdong Province

Study Background and Research Question

The ongoing global challenge of antimicrobial resistance is acutely manifested in carbapenem-resistant Enterobacteriaceae (CRE), where carbapenem-resistant Enterobacter cloacae (CREC) represents a particularly problematic subset. The COVID-19 pandemic has exacerbated these issues, with altered antibiotic use patterns and healthcare disruptions accelerating the emergence and dissemination of drug-resistant strains. Despite growing clinical concern, detailed epidemiological and molecular investigations into the diversity, mobility, and transmission of carbapenemase-encoding genes (CEGs) in CREC remain limited—especially in large, complex hospital systems. The reference study by Chen et al. addresses this gap by analyzing 54 CREC isolates from eight teaching hospitals in Guangdong, China, collected between December 2022 and June 2024.

Key Innovation from the Reference Study

The central innovation of the study lies in its comprehensive mapping of CEG prevalence, plasmid versus chromosomal localization, and the dynamics of horizontal gene transfer in clinical CREC isolates during the COVID-19 era. Notably, it quantifies the relative abundance and mobility of clinically important carbapenemase genes—especially bla_NDM-1—across both genetic compartments and diverse mobile genetic elements. By coupling molecular genotyping with conjugation assays, the study delineates not just the resistance landscape but also the mechanisms underpinning the rapid and widespread dissemination of multidrug resistance in hospital environments.

Methods and Experimental Design Insights

The research employed a multi-faceted experimental approach:

• Sample collection: 54 non-redundant CREC strains were isolated from clinical specimens (notably sputum) across eight teaching hospitals.
• Molecular detection: Polymerase chain reaction (PCR) was used to screen for carbapenemase genes (bla_NDM-1, bla_IMP, bla_KPC-2), and the presence of mobile genetic elements (MGEs).
• Plasmid elimination and localization: Variable temperature SDS plasmid curing differentiated chromosomal versus plasmid-borne CEGs.
• Resistance profiling: Broth microdilution determined susceptibility to major antibiotics, comparing CEG-positive and negative groups.
• Conjugation assays: Mating experiments assessed the transferability of plasmid-encoded CEGs.
• Genotyping: ERIC-PCR and NTSYS clustering classified clonal relationships among isolates.

This rigorous design enabled both quantitative and qualitative assessment of gene prevalence, genetic context, and dissemination capacity.

Core Findings and Why They Matter

The results reveal several pivotal patterns:

• High CEG Prevalence: 85.2% (46/54) of CREC isolates harbored at least one CEG, with bla_NDM-1 dominating (found in 79.6% of CEG-positive isolates).
• Genetic Localization: 33.3% carried bla_NDM-1 on both chromosomes and plasmids, while 46.3% had it exclusively on plasmids—highlighting the importance of mobile elements for gene dissemination.
• Antibiotic Resistance: Strains positive for CEGs exhibited significantly higher resistance rates to imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin compared to CEG-negative isolates (P<0.05).
• Gene Transferability: Conjugation experiments succeeded in transferring CEGs in 95.7% of attempts (44/46), with near-complete transfer rates for bla_NDM-1 and bla_IMP plasmids.
• Mobile Genetic Elements: Six types of MGEs were detected, led by ISEcp1 (present in 87% of isolates), often in combination, facilitating gene mobility.
• Clonal Diversity: Genotyping divided isolates into 17 types, with high-prevalence types (E and G) spanning multiple hospitals and departments.
• Epidemiological Trends: Higher detection rates were observed among male and elderly patients, in respiratory medicine wards, and in sputum samples.

These findings underscore both the scale and the complexity of CEG dissemination in hospital settings. The dominance of plasmid-borne bla_NDM-1, combined with efficient horizontal gene transfer, elevates the risk of rapid, inter-strain resistance acquisition, challenging both infection control and therapeutic options.

Comparison with Existing Internal Articles

Previous internal resources have examined the role of glycylcycline antibiotics—particularly Tigecycline—in research targeting multidrug-resistant organisms. For instance, "Tigecycline’s Role in Combating Plasmid-Mediated Resistance" contextualizes how this bacteriostatic protein synthesis inhibitor can be leveraged against bacteria with complex, plasmid-borne resistance mechanisms, such as those described in the present study. Similarly, "Tigecycline: Applied Workflows Against Multidrug-Resistant Pathogens" translates transmission dynamics data into practical protocols for experimental infection models.

What sets the present reference study apart is its direct mapping of CEG location (chromosome vs. plasmid) and the demonstrated high efficiency of gene transfer in hospital-derived CREC strains. These insights offer a more granular framework for designing laboratory models that authentically recapitulate the mechanisms driving clinical resistance outbreaks, informing not just antibiotic selection but also the design of transmission-blocking strategies.

Limitations and Transferability

Several caveats should be considered:

• Geographical Scope: The isolates were all collected from Guangdong Province hospitals, which may limit the generalizability of observed epidemiological trends to other regions.
• Gene Focus: While bla_NDM-1, bla_IMP, and bla_KPC-2 were the primary targets, other rare or emerging CEGs were not comprehensively screened.
• Clinical Data: Although patient demographics were analyzed, detailed clinical outcomes and antibiotic exposure histories were not included.
• Experimental Models: The study focuses on in vitro and ex vivo analyses; in vivo transmission and efficacy studies are needed for translational validation.

Nevertheless, the fundamental molecular mechanisms and resistance patterns described are broadly relevant for researchers modeling multidrug resistance, designing diagnostic assays, or testing new antimicrobial agents.

Protocol Parameters

• Sample collection: Isolate non-redundant CREC strains from diverse clinical specimens, emphasizing respiratory samples where prevalence is highest.
• Genetic screening: Use PCR assays to detect carbapenemase-encoding genes and associated mobile genetic elements, prioritizing bla_NDM-1 for its high transferability.
• Gene localization: Employ variable temperature SDS plasmid elimination to distinguish chromosomal from plasmid-borne resistance genes in experimental setups.
• Conjugation assays: Conduct mating experiments to evaluate the transferability of plasmid-encoded CEGs; expect success rates >90% for bla_NDM-1 and bla_IMP based on current evidence.
• Antibiotic susceptibility: Use broth microdilution for resistance profiling, particularly when benchmarking multidrug-resistant phenotypes.
• Genotyping: Apply ERIC-PCR and cluster analysis to assess clonal diversity and epidemiological spread in laboratory or surveillance cohorts.

Research Support Resources

For researchers building models of multidrug resistance or evaluating interventions against carbapenemase-producing Enterobacteriaceae, tools that target protein translation inhibition remain crucial. Tigecycline (SKU A5226), a leading glycylcycline antibiotic, is widely used in cellular and in vivo models for its broad-spectrum activity against multidrug-resistant and carbapenemase-producing strains, as reported in the product dossier. Protocols can be adapted to incorporate Tigecycline in experimental validation of resistance mechanisms or in efficacy models for glycopeptide-intermediate or methicillin-resistant staphylococci. For further workflow guidance, internal reviews such as "Tigecycline: Applied Workflows Against Multidrug-Resistant Pathogens" provide actionable protocols and troubleshooting insights tailored to advanced infection research.